| # | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating | 
|---|
 
																	MiMedx Group (NASDAQ:MDXG) reported quarterly earnings of $0.15 per share which beat the analyst consensus estimate of $0.07 by...
 
																	
 
																	Cantor Fitzgerald analyst Ross Osborn maintains MiMedx Group (NASDAQ:MDXG) with a Overweight and raises the price target fro...
 
																	
 
																	 
																	MiMedx Group, Inc. (NASDAQ:MDXG) ("MIMEDX" or the "Company") and Vaporox, Inc. ("Vaporox") today jointl...
 
																	
 
																	Cantor Fitzgerald analyst Ross Osborn reiterates MiMedx Group (NASDAQ:MDXG) with a Overweight and maintains $11 price target.
